yesterday they welcomed the findings of coroner patrick mcgurgan, who criticised the staff caring for mrs cavanagh over a series of missed opportunities..may 17, 2018.

why novartis� landmark cancer drug approval is great news for bluebird.

bother for hernandez stemmed in july 2017, when she suffered a stroke that left her partially blind, which her.

.

eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention...

.

"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened.